Gypenosides suppress fibrosis of the renal NRK-49F cells by targeting miR-378a-5p through the PI3K/AKT signaling pathway
- 7 April 2023
- journal article
- research article
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 311, 116466
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81573716, 82274242)
- Natural Science Foundation of Beijing Municipality (7172126)
- Beijing University of Chinese Medicine (2019-JYB-TD-006)
- National Postdoctoral Program for Innovative Talents (BX20220329)
This publication has 39 references indexed in Scilit:
- Proliferation, survival and metabolism: the role of PI3K/AKT/mTOR signalling in pluripotency and cell fate determinationDevelopment, 2016
- Tubulointerstitial nephritis: diagnosis, treatment, and monitoringPediatric Nephrology, 2016
- Fibrosis — A Common Pathway to Organ Injury and FailureNew England Journal of Medicine, 2015
- MicroRNAs in renal fibrosisFrontiers in Physiology, 2015
- Origin of myofibroblasts and cellular events triggering fibrosisKidney International, 2015
- Anti-Cancer Effect and the Underlying Mechanisms of Gypenosides on Human Colorectal Cancer SW-480 CellsPLOS ONE, 2014
- Cellular and molecular mechanisms of renal fibrosisNature Reviews Nephrology, 2011
- Gypenosides inhibit renal fibrosis by regulating expression of related genes in rats with unilateral ureteral obstructionJournal Of Nephrology, 2010
- The Role of Tubulointerstitial Inflammation in the Progression of Chronic Renal FailureNephron Clinical Practice, 2010
- The molecular mechanism of gypenosides-induced G1 growth arrest of rat hepatic stellate cellsJournal of Ethnopharmacology, 2008